Peter Johnström
AstraZeneca (United Kingdom) · 127 works · 5,177 citations · h-index 29
Top works
- Imaging Atherosclerotic Plaque Inflammation With [ 18 F]-Fluorodeoxyglucose Positron Emission Tomography
- Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity
- Positron Emission Tomography Compared with Magnetic Resonance Imaging and Computed Tomography in Supratentorial Gliomas Using Multiple Stereotactic Biopsies as Reference
- Positron Emission Tomography with 11 C-Methionine and Computed Tomography of Intracranial Tumours Compared with Histopathologic Examination of Multiple Biopsies
- Preparation of 11C-labelled raclopride, a new potent dopamine receptor antagonist: Preliminary PET studies of cerebral dopamine receptors in the monkey
- PET Study of Methionine Accumulation in Glioma and Normal Brain Tissue
- Clinical Validation of 18 F-AZD4694, an Amyloid-β–Specific PET Radioligand
- The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models
- Preclinical Comparison of the Blood–brain barrier Permeability of Osimertinib with Other EGFR TKIs
- Characterization of AZD4694, a novel fluorinated Aβ plaque neuroimaging PET radioligand
- Comparison of the Accumulation Kinetics of L-(Methyl- 11 C)-Methionine and D-(Methyl- 11 C)-Methionine in Brain Tumors Studied with Positron Emission Tomography
- Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson’s disease
- Preclinical comparison of the blood brain barrier (BBB) permeability of osimertinib (AZD9291) with other irreversible next generation EGFR TKIs
- Discovery and Evaluation of Clinical Candidate AZD3759, a Potent, Oral Active, Central Nervous System-Penetrant, Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
- D-Methionine and cisplatin ototoxicity in the guinea pig: D-methionine influences cisplatin pharmacokinetics
- Preparation and preliminary positron emission tomography studies of 11C-Ro 15-1788, a selective benzodiazepine receptor antagonist.
- In vivo evaluation of the biodistribution of 11C-labeled PD153035 in rats without and with neuroblastoma implants
- Relationship between Flow-Metabolism Uncoupling and Evolving Axonal Injury after Experimental Traumatic Brain Injury
- Strategies for reducing isotopic dilution in the synthesis of 18F-labeled polyfluorinated ethyl groups
- Positron emission tomography using 18F‐labelled endothelin‐1 reveals prevention of binding to cardiac receptors owing to tissue‐specific clearance by ETB receptors in vivo